Zoono Group Limited (AU:ZNO)
ASX:ZNO
Want to see AU:ZNO full AI Analyst Report?
ZNO Stock Chart & Stats
AU$0.08
<AU$0.01(8.00%)
At close: 4:00 PM EST
AU$0.08
<AU$0.01(8.00%)
Day’s Range― - ―
52-Week RangeAU$0.03 - AU$0.18
Previous CloseN/A
Volume41.30K
Average Volume (3M)153.26K
Market Cap
AU$28.84M
Enterprise ValueAU$28.99M
Total Cash (Recent Filing)AU$475.33K
Total Debt (Recent Filing)AU$625.70K
Price to Earnings (P/E)―
Beta0.19
Next Earnings
Aug 20, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.01
Shares Outstanding406,211,760
10 Day Avg. Volume257,173
30 Day Avg. Volume153,260
Financial Highlights & Ratios
PEG Ratio0.04
Price to Book (P/B)3.62
Price to Sales (P/S)9.30
P/FCF Ratio-6.83
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Low Leverage / Conservative Debt ProfileThe company’s low debt-to-equity (~0.18) and minimal FY2025 debt reduce near-term solvency and interest burden, giving management time to pursue a turnaround or restructure. Lower leverage is a durable stabilizer versus highly indebted peers when cash flows are weak.
Top-line Recovery In FY2025A 14.8% revenue increase in FY2025 signals renewed demand and ability to grow sales across consumer and institutional channels. While the base is small, sustained revenue growth is a durable prerequisite for restoring margins and benefits long-term operating leverage if maintained.
Positioning In Hygiene And Long‑lasting SanitisationOperating in infection‑prevention and long‑lasting antimicrobial products addresses structural hygiene demand across consumer, commercial and institutional markets. Proprietary long‑lasting formulations can create stickier customer relationships and recurring institutional contracts over the medium term.
Bears Say
Deep And Persistent UnprofitabilitySeverely negative gross profit and a net margin near -314% indicate a fundamental problem in pricing, cost structure, or mix. Persistent structural unprofitability erodes stakeholder confidence, requires ongoing financing, and makes sustainable earnings recovery a material multi‑quarter challenge.
Consistent Negative Operating Cash FlowMulti‑year negative operating and free cash flows show the business cannot fund operations internally. This structural cash burn raises financing and dilution risk, limits ability to invest in sales or R&D, and constrains recovery even if top-line trends improve.
Material Erosion Of Equity CapitalA large decline in equity reduces the balance‑sheet buffer against losses and increases vulnerability to shocks. With capital eroded, the company faces weaker leverage to secure funding, higher dilution risk, and reduced capacity to absorb continued operational underperformance.
Zoono Group Limited News
ZNO FAQ
What was Zoono Group Limited’s price range in the past 12 months?
Zoono Group Limited lowest share price was AU$0.03 and its highest was AU$0.18 in the past 12 months.
What is Zoono Group Limited’s market cap?
Zoono Group Limited’s market cap is AU$28.84M.
When is Zoono Group Limited’s upcoming earnings report date?
Zoono Group Limited’s upcoming earnings report date is Aug 20, 2026 which is in 86 days.
How were Zoono Group Limited’s earnings last quarter?
Zoono Group Limited released its earnings results on Feb 19, 2026. The company reported -AU$0.003 earnings per share for the quarter, missing the consensus estimate of N/A by -AU$0.003.
Is Zoono Group Limited overvalued?
According to Wall Street analysts Zoono Group Limited’s price is currently Overvalued.
Does Zoono Group Limited pay dividends?
Zoono Group Limited pays a Notavailable dividend of AU$0.03 which represents an annual dividend yield of N/A. See more information on Zoono Group Limited dividends here
What is Zoono Group Limited’s EPS estimate?
Zoono Group Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Zoono Group Limited have?
Zoono Group Limited has 406,211,760 shares outstanding.
What happened to Zoono Group Limited’s price movement after its last earnings report?
Zoono Group Limited reported an EPS of -AU$0.003 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 1.515%.
Which hedge fund is a major shareholder of Zoono Group Limited?
Currently, no hedge funds are holding shares in AU:ZNO
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Zoono Group Limited Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
85.18%
12-Months-Change
Fundamentals
Return on Equity
-108.90%
Trailing 12-Months
Asset Growth
-23.69%
Trailing 12-Months
Company Description
Zoono Group Limited
Zoono Group Limited, together with its subsidiaries, engages in the research, development, and sale of a range of antimicrobial products in New Zealand and internationally. The company's products include hand sanitizers, textile applicators, mould remediation, and surface sanitizers. It serves airlines, healthcare, childcare, facilities management, transportation, education, and hospitality sectors. The company was incorporated in 1986 and is headquartered in Auckland, New Zealand.
Technical Analysis
Skin Elements Limited
―
Food Revolution Group Ltd.
―
Fiji Kava Limited
―
―
Nutritional Growth Solutions Ltd.
―
Options Prices
Currently, No data available
---